Engi̇n Köse

682 total citations
74 papers, 412 citations indexed

About

Engi̇n Köse is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Engi̇n Köse has authored 74 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Clinical Biochemistry, 21 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in Engi̇n Köse's work include Metabolism and Genetic Disorders (31 papers), Lysosomal Storage Disorders Research (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). Engi̇n Köse is often cited by papers focused on Metabolism and Genetic Disorders (31 papers), Lysosomal Storage Disorders Research (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). Engi̇n Köse collaborates with scholars based in Türkiye, United States and Switzerland. Engi̇n Köse's co-authors include Nur Arslan, Orkide Güzel, Nejat Aksu, Fatma Tuba Eminoğlu, Caner Alparslan, Önder Yavaşcan, Ali Kanık, Alkan Bal, D. Bor and Ünsal Yılmaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Nutrition and Digestive Diseases and Sciences.

In The Last Decade

Engi̇n Köse

61 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Engi̇n Köse Türkiye 12 136 129 91 60 54 74 412
Maria Santulli Italy 10 37 0.3× 101 0.8× 182 2.0× 11 0.2× 36 0.7× 20 630
Didier Eyer France 10 56 0.4× 98 0.8× 129 1.4× 29 0.5× 99 1.8× 22 510
J. McConnell United Kingdom 11 231 1.7× 183 1.4× 121 1.3× 43 0.7× 59 1.1× 15 516
Richard K. Mathis United States 11 90 0.7× 87 0.7× 72 0.8× 13 0.2× 73 1.4× 23 494
José Carlos Rodríguez-Pérez Spain 12 23 0.2× 94 0.7× 83 0.9× 20 0.3× 22 0.4× 42 432
Delphine Lamireau France 11 67 0.5× 41 0.3× 75 0.8× 12 0.2× 153 2.8× 24 485
Jesús Calviño Spain 12 30 0.2× 118 0.9× 127 1.4× 8 0.1× 30 0.6× 24 529
Sheon Mary United Kingdom 13 27 0.2× 90 0.7× 127 1.4× 11 0.2× 45 0.8× 31 668
Bo S. Lindblad Sweden 11 71 0.5× 46 0.4× 69 0.8× 160 2.7× 144 2.7× 18 383
Frederick C. Johlin United States 18 24 0.2× 64 0.5× 91 1.0× 41 0.7× 50 0.9× 41 884

Countries citing papers authored by Engi̇n Köse

Since Specialization
Citations

This map shows the geographic impact of Engi̇n Köse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engi̇n Köse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engi̇n Köse more than expected).

Fields of papers citing papers by Engi̇n Köse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Engi̇n Köse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engi̇n Köse. The network helps show where Engi̇n Köse may publish in the future.

Co-authorship network of co-authors of Engi̇n Köse

This figure shows the co-authorship network connecting the top 25 collaborators of Engi̇n Köse. A scholar is included among the top collaborators of Engi̇n Köse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Engi̇n Köse. Engi̇n Köse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köse, Engi̇n, Figen Özçay, Halil İbrahim Aydın, et al.. (2025). Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye. Journal of Pediatric Endocrinology and Metabolism. 38(4). 391–398. 1 indexed citations
2.
3.
Köse, Engi̇n, et al.. (2025). Methylene Blue for Refractory Shock in A Neonate. Zeitschrift für Geburtshilfe und Neonatologie. 229(6). 450–452.
4.
Köse, Engi̇n, et al.. (2024). Türkiye’s First Multidisciplinary Gene Therapy Education Program: History and Plans for the Future. Journal of Contemporary Medicine. 14(2). 77–82.
5.
Köse, Engi̇n, et al.. (2024). Two Turkish patients with Primary Coenzyme Q10 Deficiency-7: case report and literature review. Journal of Pediatric Endocrinology and Metabolism. 37(3). 260–270.
6.
Köse, Engi̇n, Miraç Yıldırım, Suat Fítöz, et al.. (2024). Is Ultrasonography a Reliable Approach for the Evaluation of Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis?. Pediatric Neurology. 155. 171–176.
7.
Yıldırım, Miraç, et al.. (2024). Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center. Brain and Development. 46(6). 213–218. 3 indexed citations
8.
Köse, Engi̇n, et al.. (2023). A different approach to the evaluation of the genotype-phenotype relationship in biotinidase deficiency: repeated measurement of biotinidase enzyme activity. Journal of Pediatric Endocrinology and Metabolism. 36(11). 1061–1071. 4 indexed citations
9.
Kendirli, Tanıl, Engi̇n Köse, Emel Okulu, et al.. (2023). Evaluation of the efficacy and associated complications of regional citrate anticoagulation in neonates: experience from a fourth level neonatal intensive care unit. European Journal of Pediatrics. 182(11). 4897–4908. 2 indexed citations
10.
Bakırarar, Batuhan, et al.. (2022). Pros and Cons of Telemedicine for Inherited Metabolic Disorders in a Developing Country During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 28(11). 1604–1612. 5 indexed citations
11.
Köse, Engi̇n, Ceyda Tuna Kırşaçlıoğlu, Fatih Süheyl Ezgü, et al.. (2022). Co-Occurring Atypical Galactosemia and Wilson Disease. Molecular Syndromology. 13(5). 454–458. 1 indexed citations
12.
Eminoğlu, Fatma Tuba, Engi̇n Köse, Emel Okulu, et al.. (2021). Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for. Pediatrics International. 64(1). e14953–e14953. 2 indexed citations
13.
Köse, Engi̇n, et al.. (2021). A case with Gaucher disease unable to reach enzyme replacement therapy because of COVID-19 quarantine: The first case from Turkey. Turkish Archives of Pediatrics. 56(3). 270–271. 2 indexed citations
14.
Köse, Engi̇n, et al.. (2021). An Atypical Presentation of Mevalonate Kinase Deficiency in Response to Colchicine Treatment. Molecular Syndromology. 13(2). 146–151. 1 indexed citations
15.
Köse, Engi̇n, et al.. (2021). A Mild Phenotype of Mitochondrial DNA Depletion Syndrome Type 13 with a Novel <b><i>FBXL4</i></b> Variant. Molecular Syndromology. 12(5). 294–299. 1 indexed citations
16.
Yıldırım, Miraç, et al.. (2020). Status dystonicus associated with CLN8 disease. Brain and Development. 43(4). 571–575. 4 indexed citations
17.
Köse, Engi̇n, et al.. (2020). Different clinical presentation in a patient with two novel pathogenic variants of the FBXL4 gene. The Turkish Journal of Pediatrics. 62(4). 652–656. 4 indexed citations
18.
Köse, Engi̇n, Orkide Güzel, Korcan Demir, & Nur Arslan. (2017). Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy. Journal of Pediatric Endocrinology and Metabolism. 30(4). 411–416. 21 indexed citations
19.
Köse, Engi̇n, Uluç Yiş, Semra Hız, & Nur Arslan. (2017). A novel mutation in the glycine decarboxylase gene in patient with non-ketotic hyperglycinemia. Neurosciences. 22(2). 131–133. 2 indexed citations
20.
Anıl, Murat, et al.. (2012). Çocuklarda B12 vitamin düzeyi ve periferik tam kan sayımı değerleri ile ilişkisi. 2(2). 75–79.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Santulli Breakdown of academic impact, for papers by Didier Eyer Breakdown of academic impact, for papers by J. McConnell Breakdown of academic impact, for papers by Richard K. Mathis Breakdown of academic impact, for papers by José Carlos Rodríguez-Pérez Breakdown of academic impact, for papers by Delphine Lamireau Breakdown of academic impact, for papers by Jesús Calviño Breakdown of academic impact, for papers by Sheon Mary Breakdown of academic impact, for papers by Bo S. Lindblad Breakdown of academic impact, for papers by Frederick C. Johlin
Rankless by CCL
2026